Researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine using virus-like ...

A more affordable, lower-risk polio vaccine is on the horizon, research led by the University of Leeds has found.

Researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine using virus-like particles (VLPs). These particles mimic the outer protein shell of poliovirus ...

Creative Diagnostics has launched the Norovirus VP1 VLP Panel, a new research tool designed ... with only three known to infect humans. The virus protein 1 (VP1), a critical component in the ...

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced the launch of ...

ProBioGen has expanded its protein and viral vector manufacturing capabilities at its Berlin headquarters, reinforcing its ...

This partnership comprises a technology transfer of the current drug product manufacturing process for the Chikungunya Vaccine ...

COPENHAGEN, Denmark, February 28, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the European Commission has granted marketing authorization in Europe for VIMKUNYA ® for active ...

Copenhagen, Denmark Monday, March 10, 2025, 11:00 Hrs [IST] ...

Biological E (BE) has partnered with Bavarian Nordic to produce the Chikungunya vaccine, VIMKUNYA CHIKV VLP, for low and ...

University of Leeds researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine ...